Cargando…
CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
SIMPLE SUMMARY: Dipeptidyl peptidase (DPP)-4 inhibitor is widely used for type 2 diabetes. Although DPP-4/CD26 has been recognized as both a suppressor and inducer in tumor biology due to its various functions, how DPP-4 inhibitor affects cancer progression in diabetic patients is still unknown. The...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124456/ https://www.ncbi.nlm.nih.gov/pubmed/34063285 http://dx.doi.org/10.3390/cancers13092191 |